Marisa Zammit asks Mike about his background, how Mike came to join Imagion and how Mike thinks Imagion’s technology could transform the imaging industry.
The Unanswered Question in Prostate Cancer Diagnosis
September 24, 2026
Separating lethal disease from indolent disease remains the persistent difficulty, and molecular MRI may offer a way to see the difference. Prostate cancer is the